Hortobagyi G - Search Results

1

Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.

Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. Xu XC, et al. Among authors: hortobagyi g. Cancer Res. 1997 Nov 15;57(22):4992-6. Cancer Res. 1997. PMID: 9371489

2

Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.

Chen T, Dhingra K, Sahin A, Sneige N, Hortobagyi G, Aldaz CM. Chen T, et al. Among authors: hortobagyi g. Breast Cancer Res Treat. 1996;39(2):177-85. doi: 10.1007/BF01806184. Breast Cancer Res Treat. 1996. PMID: 8872326

3

Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.

Dhingra K, Sahin A, Supak J, Kim SY, Hortobagyi G, Hittelman WN. Dhingra K, et al. Among authors: hortobagyi g. Breast Cancer Res Treat. 1992;23(3):201-10. doi: 10.1007/BF01833516. Breast Cancer Res Treat. 1992. PMID: 1463859

4

STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis.

Royce ME, Xia W, Sahin AA, Katayama H, Johnston DA, Hortobagyi G, Sen S, Hung MC. Royce ME, et al. Among authors: hortobagyi g. Cancer. 2004 Jan 1;100(1):12-9. doi: 10.1002/cncr.11879. Cancer. 2004. PMID: 14692019 Free article.

5

Phase II study of deoxyspergualin in metastatic breast cancer.

Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, Holmes F, Buzdar A, Fraschini G, Hortobagyi G. Dhingra K, et al. Among authors: hortobagyi g. Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965. Invest New Drugs. 1994. PMID: 7896543 Clinical Trial.

6

c-erbB-2 amplification in node-negative human breast cancer.

Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G. Ro JS, et al. Among authors: hortobagyi g. Cancer Res. 1989 Dec 15;49(24 Pt 1):6941-4. Cancer Res. 1989. PMID: 2573424

7

HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.

Yang Z, Bagheri-Yarmand R, Balasenthil S, Hortobagyi G, Sahin AA, Barnes CJ, Kumar R. Yang Z, et al. Among authors: hortobagyi g. Clin Cancer Res. 2003 Aug 1;9(8):3198-203. Clin Cancer Res. 2003. PMID: 12912973

8

Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.

Barcenas CH, Raghavendra A, Sinha AK, Syed MP, Hsu L, Patangan MG Jr, Chavez-MacGregor M, Shen Y, Hortobagyi GH, Valero V, Giordano SH, Ueno NT, Tripathy D. Barcenas CH, et al. Among authors: hortobagyi gh. Cancer. 2017 Jul 1;123(13):2422-2431. doi: 10.1002/cncr.30618. Epub 2017 Feb 15. Cancer. 2017. PMID: 28199747 Free PMC article.

9

Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer.

Xia WY, Lien HC, Wang SC, Pan Y, Sahin A, Kuo YH, Chang KJ, Zhou X, Wang H, Yu Z, Hortobagyi G, Shi DR, Hung MC. Xia WY, et al. Among authors: hortobagyi g. Breast Cancer Res Treat. 2006 Aug;98(3):295-301. doi: 10.1007/s10549-006-9162-7. Epub 2006 Jun 3. Breast Cancer Res Treat. 2006. PMID: 16752078

10

Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.

Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, Valero V, Hortobagyi G, Atchley D, Arun B. Yang WT, et al. Among authors: hortobagyi g. Breast Cancer Res Treat. 2008 Oct;111(3):405-10. doi: 10.1007/s10549-007-9810-6. Epub 2007 Nov 17. Breast Cancer Res Treat. 2008. PMID: 18026834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,209 results

Search Page

Filters